Pain management in pancreatic cancer

Cancers

Volumn 3, Issue 1, 2011, Pages 43-60

  Hameed, Mariam ^a   Hameed, Haroon ^a   Erdek, Michael ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Intrathecal therapy; Neurolytic celiac plexus block; Opioids; Pain; Pancreatic cancer

Indexed keywords

ACETYLSALICYLIC ACID; CAPSAICIN; CODEINE; FENTANYL; FLUOROURACIL; GEMCITABINE; HERPESVIRUS VECTOR; HYDROCODONE; HYDROMORPHONE; IBUPROFEN; LOCAL ANESTHETIC AGENT; METHADONE; MORPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA CONOTOXIN MVIIA; OPIATE; OXYCODONE; PARACETAMOL; PHENTOLAMINE; PREPROENKEPHALIN; RADIOACTIVE IODINE; RESINIFERATOXIN; VANILLOID RECEPTOR;

ANALGESIA; CANCER ADJUVANT THERAPY; CANCER PAIN; CANCER RADIOTHERAPY; CANCER SURVIVAL; DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG IMPLANT; DRUG MECHANISM; DRUG UTILIZATION; GENE THERAPY; HUMAN; HYPOTENSION; INTRATHECAL DRUG ADMINISTRATION; NERVE BLOCK; NERVE SURGERY; NEUROLYSIS; NEUROLYTIC CELIAC PLEXUS BLOCK; PAIN ASSESSMENT; PANCREAS CANCER; PANCREATITIS; PATIENT CARE; PRACTICE GUIDELINE; PROGNOSIS; QUALITY OF LIFE; REVIEW; SPLANCHNICECTOMY; TACHYCARDIA; TUMOR LOCALIZATION;

EID: 79953712023     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3010043     Document Type: Review

References (62)

1. Lau, M.K.; Davila, J.A.; Shaib, Y.H. Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States. Pancreas 2010, 39, 458-462.
2. Shoup, M.; Conlon, K.C.; Klimstra, D.; Brennan, M.F. Is extended resection for adenocarcinoma of the body and tail of the pancreas justified? J. Gastrointest. Surg. 2003, 7, 946-952.
3. Morgan, K.A.; Adams, D.B. Solid tumors of the body and tail of the pancreas. Surg. Clin. North. Am. 2010, 90, 287-307.
4. Yan, B.M.; Myers, R.P. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am. J. Gastroenterol. 2007, 102, 430-438.
5. Lebovits, A.H.; Lefkowitz, M. Pain management of pancreatic carcinoma: a review. Pain 1989, 36, 1-11.
6. Penman, I.D. Coeliac plexus neurolysis. Best Pract. Res. Clin. Gastroentero. 2009, 23, 761-766.
7. Caraceni, A.; Portenoy, R.K. Pain management in patients with pancreatic carcinoma. Cancer 1996, 78, 639-653.
8. WHO. Available online: http://www.who.int/cancer/palliative/painladder/en/ (accessed on 18 May 2010).
9. Coyle, N.; Adelhardt, J.; Foley, K.M. Changing patterns in pain, drug use and routes of administration in the advanced cancer patient. Pain 1987, 30, S339.
10. National Comprehensive Cancer Network, Adult Cancer Pain Guidelines. Available online: http://www.nccn.org/professionals/physician_gls/PDF/pain.pdf (accessed on 12 November 2010).
11. Foley, K.M. Pain syndromes and pharmacologic management of pancreatic cancer pain. J. Pain Symptom Manag. 1988, 3, 176-187.
12. Carr, D.; Goudas, L; Lawrence, D.; Pirl, W.; Lau, J.; DeVine, D.; Kupelnick, B.; Miller, K. Management of cancer symptoms: pain, depression, and fatigue. Evid. Rep. Technol. Assess. (Summ.) 2002, 61, 1-5.
13. Smith, T.J.; Staats, P.S.; Deer, T.; Stearns, L.J.; Rauck, R.L.; Boortz-Marx, R.L.; Buchser, E.; Català, E.; Bryce, D.A.; Coyne, P.J.; et al. Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J. Clin. Oncol. 2002, 20, 4040-4049.
14. Kappis, M. Erfahrungen mit localanasthesie bie bauchoperationen. Verh. Dtsch. Gesellsch. Chir. 1914, 43, 87-89.
15. Eisenberg, E.; Carr, D.B.; Chalmers, T.C. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth. Analg. 1995, 80, 290-295.
16. Sharfman, W.H.; Walsh, T.D. Has the analgesic efficacy of neurolytic celiac plexus block been demonstrated in pancreatic cancer pain? Pain 1990, 41, 267-271.
17. Mercadante, S.; Nicosia, F. Celiac plexus block: A reappraisal. Reg. Anesth. Pain Med. 1998, 23, 37-48.
18. Ischia, S.; Ischia, A.; Polati, E.; Finco, G. Three posterior percutaneous celiac plexus block techniques. A prospective, randomized study in 61 patients with pancreatic cancer pain. Anesthesiology 1992, 76, 534-540.
19. Süleyman Ozyalçin, N.; Talu, G.K.; Camlica, H.; Erdine, S. Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer pain. Eur. J. Pain 2004, 8, 539-545.
20. Wiersema, M.J.; Wiersema, L.M. Endosonography-guided celiac plexus neurolysis. Gastrointest. Endosc. 1996, 44, 656-662.
21. Levy, M.J.; Topazian, M.D.; Wiersema, M.J.; Clain, J.E.; Rajan, E.; Wang, K.K.; de la Mora, J.G.; Gleeson, F.C.; Pearson, R.K.; et al. Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct Ganglia neurolysis and block. Am. J. Gastroenterol. 2008, 103, 98-103.
22. Tran, Q.N.; Urayama, S.; Meyers, F.J. Endoscopic ultrasound-guided celiac plexus neurolysis for pancreatic cancer pain: a single-institution experience and review of the literature. J. Support. Oncol. 2006, 4, 460-464.
23. Gunaratnam, N.T.; Sarma, A.V.; Norton, I.D.; Wiersema, M.J. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest. Endosc. 2001, 54, 316-324.
24. Kaufman, M.; Singh, G.; Das, S.; Concha-Parra, R.; Erber, J.; Micames, C.; Gress, F. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J. Clin. Gastroenterol. 2010, 44, 127-134.
25. O'Toole, T.M.; Schmulewitz, N. Complication rates of EUS-guided celiac plexus blockade and neurolysis: results of a large case series. Endoscopy 2009, 41, 593-597.
26. Lillemoe, K.D.; Cameron, J.L.; Kaufman, H.S.; Yeo, C.J.; Pitt, H.A.; Sauter, P.K. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann. Surg. 1993, 217, 447-455, discussion 456-457.
27. Wong, G.Y.; Schroeder, D.R.; Carns, P.E.; Wilson, J.L.; Martin, D.P.; Kinney, M.O.; Mantilla, C.B.; Warner, D.O. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 2004, 291, 1092-1099.
28. Kawamata, M.; Ishitani, K.; Ishikawa, K.; Sasaki, H.; Ota, K.; Omote, K.; Namiki, A. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain 1996, 64, 597-602.
29. Polati, E.; Finco, G.; Gottin, L.; Bassi, C.; Pederzoli, P.; Ischia, S. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br. J. Surg. 1998, 85, 199-201.
30. Mercadante, S. Celiac plexus block versus analgesics in pancreatic cancer pain. Pain 1993, 52, 187-192.
31. Johnson, C.D.; Berry, D.P.; Harris, S.; Pickering, R.M.; Davis, C.; George, S.; Imrie, C.W.; Neoptolemos, J.P.; Sutton, R. An open randomized comparison of clinical effectiveness of protocol-driven opioid analgesia, celiac plexus block or thoracoscopic splanchnicectomy for pain management in patients with pancreatic and other abdominal malignancies. Pancreatology 2009, 9, 755-763.
32. Kelsen, D.P.; Portenoy, R.; Thaler, H.; Tao, Y.; Brennan, M. Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery 1997, 122, 53-59.
33. Staats, P.S.; Hekmat, H.; Sauter, P.; Lillemoe, K. The effects of alcohol celiac plexus block, pain, and mood on longevity in patients with unresectable pancreatic cancer: a double-blind, randomized, placebo-controlled study. Pain Med. 2001, 2, 28-34.
34. de Oliveira, R.; dos Reis, M.P.; Prado, W.A. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain 2004, 110, 400-408.
35. Okuyama, M.; Shibata, T.; Morita, T.; Kitada, M.; Tukahara, Y.; Fukushima, Y.; Ikeda, K.; Fuzita, J.; Shimano, T. A comparison of intraoperative celiac plexus block with pharmacological therapy as a treatment for pain of unresectable pancreatic cancer. J. Hepatobiliary Pancreat. Surg. 2002, 9, 372-375.
36. West, S.; King, V.; Carey, T.S.; Lohr, K.N.; McKoy, N.; Sutton, S.F.; Lux, L. Systems to rate the strength of scientific evidence. Evid. Rep. Technol. Assess. (Summ.) 2002, 47, 1-11.
37. Zhang, C.L.; Zhang, T.J.; Guo, Y.N.; Yang, L.Q.; He, M.W.; Shi, J.Z.; Ni, J.X. Effect of neurolytic celiac plexus block guided by computerized tomography on pancreatic cancer pain. Dig. Dis. Sci. 2008, 53, 856-860.
38. Erdek, M.A.; Halpert, D.E.; Fernández, M.G.; Cohen, S.P. Assessment of celiac plexus block and neurolysis outcomes and technique in the management of refractory visceral cancer pain. Pain Med. 2010, 11, 92-100.
39. Stefaniak, T.; Basinski, A.; Vingerhoets, A.; Makarewicz, W.; Connor, S.; Kaska, L.; Stanek, A.; Kwiecinska, B.; Lachinski, A.J.; Sledzinski, Z. A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy. Eur. J. Surg. Oncol. 2005, 31, 768-773.
40. De Cicco, M.; Matovic, M.; Bortolussi, R.; Coran, F.; Fantin, D.; Fabiani, F.; Caserta, M.; Santantonio, C.; Fracasso, A. Celiac plexus block: injectate spread and pain relief in patients with regional anatomic distortions. Anesthesiology 2001, 94, 561-565.
41. Rykowski, J.J.; Hilgier, M. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief. Anesthesiology 2000, 92, 347-354.
42. Vranken, J.H.; Zuurmond, W.W.; Van Kemenade, F.J.; Dzoljic, M. Neurohistopathologic findings after a neurolytic celiac plexus block with alcohol in patients with pancreatic cancer pain. Acta Anaesthesiol. Scand. 2002, 46, 827-830.
43. Vranken, J.H.; Zuurmond, W.W.; de Lange, J.J. Increasing the efficacy of a celiac plexus block in patients with severe pancreatic cancer pain. J. Pain Symptom Manage. 2001, 22, 66-77.
44. Noble, M.; Gress, F.G. Techniques and results of neurolysis for chronic pancreatitis and pancreatic cancer pain. Curr. Gastroenterol. Rep. 2006, 8, 99-103.
45. van Geenen, R.C.; Keyzer-Dekker, C.M.; van Tienhoven, G.; Obertop, H.; Gouma, D.J. Pain management of patients with unresectable peripancreatic carcinoma. World J. Surg. 2002, 26, 715-720.
46. Morganti, A.G.; Trodella, L.; Valentini, V.; Barbi, S.; Macchia, G.; Mantini, G.; Turriziani, A.; Cellini, N. Pain relief with short-term irradiation in locally advanced carcinoma of the pancreas. J. Palliat. Care 2003, 19, 258-262.
47. Prott, F.J.; Schönekaes, K.; Preusser, P.; Ostkamp, K.; Wagner, W.; Micke, O.; Pötter, R.; Sulkowski, U.; Rübe, C.; Berns, T.; et al. Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study. Br. J. Cancer 1997, 75, 597-601.
48. Wang, J.; Jiang, Y.; Li, J.; Tian, S.; Ran, W.; Xiu, D. Intraoperative ultrasound-guided iodine-125 seed implantation for unresectable pancreatic carcinoma. J. Exp. Clin. Cancer Res. 2009, 28, 88.
49. Li, C.P.; Chao, Y.; Chi, K.H.; Chan, W.K.; Teng, H. C; Lee, R.C.; Chang, F.Y.; Lee, S.D.; Yen, S.H. Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. Int. J. Radiat. Oncol. Biol. Phys. 2003, 57, 98-104.
50. Burton, A.W.; Rajagopal, A.; Shah, H.N.; Mendoza, T.; Cleeland, C.; Hassenbusch, S.J., 3rd; Arens, J.F. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004, 5, 239-247.
51. Stearns. L.; Boortz-Marx, R.; Du Pen, S.; Friehs, G.; Gordon, M.; Halyard, M.; Herbst, L.; Kiser, J. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. J. Support. Oncol. 2005, 3, 399-408.
52. Smith, H.S.; Deer, T.R.; Staats, P.S.; Singh, V.; Sehgal, N.; Cordner, H. Intrathecal drug delivery. Pain Physician 2008, 11, S89-S104.
53. van Dongen, R.T.; Crul, B.J.; van Egmond, J. Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients. Clin. J. Pain 1999, 15, 166-172.
54. Hartel, M.; di Mola, F.F.; Selvaggi, F.; Mascetta, G.; Wente, M.N.; Felix, K.; Giese, N.A.; Hinz, U.; Di Sebastiano, P.; Büchler, M.W.; et al. Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut 2006, 55, 519-528.
55. Lu, Y.; McNearney, T.A.; Yeomans, D.C.; Wilson, S.P.; Westlund, K.N. Treatment of pancreas with enkephalin encoding HSV-1 recombinant vector reduces inflammatory damage and behavioral sequelae in a rat pancreatitis model. Mol. Ther. 2007, 15, 1812-1819.
56. Yang, H.; McNearney, T.A.; Chu, R.; Lu, Y.; Ren, Y.; Yeomans, D.C.; Wilson, S.P.; Westlund, K.N. Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model. Mol. Pain 2008, 4, 8.
57. Westlund, K.N. Gene therapy for pancreatitis pain. Gene Ther. 2009, 16, 483-492.
58. McCleane, G.J. Intravenous phentolamine mesylate alleviates the pain of pancreatic carcinoma. Pain 1997, 73, 263-264.
59. Raja, S.N.; Treede, R.D.; Davis, K.D.; Campbell, J.N. Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiology 1991, 74, 691-698.
60. Galer, B.S. Peak pain relief is delayed and duration of relief is extended following intravenous phentolamine infusion. Reg. Anesth. 1995, 20, 444-447.
61. Yasukawa, M.; Yasukawa, K.; Kamiizumi, Y.; Yokoyama, R. Intravenous phentolamine infusion alleviates the pain of abdominal visceral cancer, including pancreatic carcinoma. J. Anesth. 2007, 21, 420-423.
62. Raja, S.N.; Turnquist, J.L.; Meleka, S.; Campbell, J.N. Monitoring adequacy of a-adrenoceptor blockade following systemic phentolamine administration. Pain 1996, 64, 197-204.